跳至主要内容
临床试验/JPRN-UMIN000017148
JPRN-UMIN000017148已完成2 期

An open randomized controlled study of topical B blocker gel for the treatment of infantile hemangioma: Comparison of safety and efficacy among topical 0%, 1% 5% B blocker gel. - A controlled study of B blocker gel for the treatment of infantile hemangioma

Chiba University0 个研究点目标入组 19 人开始时间: 2015年7月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
19

研究概览

简要总结

In the PPS, the main endpoint, the rate of change in the average number of brightness in the area where the tumor exists after 6 months, three groups are same, ie, 0.9. There was no difference. A difference in the average number of brightness in the area where the tumor exists after 6 months was examined. A tendency was observed that the number of brightness decreased.

研究设计

研究类型
Interventional

入排标准

年龄范围
2years-old 至 15years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have asthma, cardiovascular malformation, diabetes, medication (including adrenaline, beta-blocker, calcium antagonist agent, digitalis product, CYP2D6 inhibitor), other skin disease, many infant hemangioma, congenital hemangioma. Patients who are ruled unfit to this study.

研究者

相似试验

An open randomized controlled study of topical B... | 临床试验